These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
917 related articles for article (PubMed ID: 21821866)
1. Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro. Guiducci S; Manetti M; Romano E; Mazzanti B; Ceccarelli C; Dal Pozzo S; Milia AF; Bellando-Randone S; Fiori G; Conforti ML; Saccardi R; Ibba-Manneschi L; Matucci-Cerinic M Ann Rheum Dis; 2011 Nov; 70(11):2011-21. PubMed ID: 21821866 [TBL] [Abstract][Full Text] [Related]
2. Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis. Cipriani P; Guiducci S; Miniati I; Cinelli M; Urbani S; Marrelli A; Dolo V; Pavan A; Saccardi R; Tyndall A; Giacomelli R; Cerinic MM Arthritis Rheum; 2007 Jun; 56(6):1994-2004. PubMed ID: 17530639 [TBL] [Abstract][Full Text] [Related]
3. Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cells. Van Overstraeten-Schlögel N; Beguin Y; Gothot A Eur J Haematol; 2006 Jun; 76(6):488-93. PubMed ID: 16494621 [TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats. Tang J; Wang J; Yang J; Kong X; Zheng F; Guo L; Zhang L; Huang Y Eur J Cardiothorac Surg; 2009 Oct; 36(4):644-50. PubMed ID: 19524448 [TBL] [Abstract][Full Text] [Related]
5. Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications. Cipriani P; Franca Milia A; Liakouli V; Pacini A; Manetti M; Marrelli A; Toscano A; Pingiotti E; Fulminis A; Guiducci S; Perricone R; Kahaleh B; Matucci-Cerinic M; Ibba-Manneschi L; Giacomelli R Arthritis Rheum; 2006 Sep; 54(9):3022-33. PubMed ID: 16948134 [TBL] [Abstract][Full Text] [Related]
6. The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation. Bhakta S; Hong P; Koc O Cardiovasc Revasc Med; 2006; 7(1):19-24. PubMed ID: 16513519 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis. Manetti M; Guiducci S; Romano E; Ceccarelli C; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M Circ Res; 2011 Jul; 109(3):e14-26. PubMed ID: 21636803 [TBL] [Abstract][Full Text] [Related]
8. Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Son BR; Marquez-Curtis LA; Kucia M; Wysoczynski M; Turner AR; Ratajczak J; Ratajczak MZ; Janowska-Wieczorek A Stem Cells; 2006 May; 24(5):1254-64. PubMed ID: 16410389 [TBL] [Abstract][Full Text] [Related]
9. Functional interleukin-7/interleukin-7Ralpha, and SDF-1alpha/CXCR4 are expressed by human periodontal ligament derived mesenchymal stem cells. Trubiani O; Isgro A; Zini N; Antonucci I; Aiuti F; Di Primio R; Nanci A; Caputi S; Paganelli R J Cell Physiol; 2008 Mar; 214(3):706-13. PubMed ID: 17894415 [TBL] [Abstract][Full Text] [Related]
10. Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations. Psaltis PJ; Paton S; See F; Arthur A; Martin S; Itescu S; Worthley SG; Gronthos S; Zannettino AC J Cell Physiol; 2010 May; 223(2):530-40. PubMed ID: 20162565 [TBL] [Abstract][Full Text] [Related]
11. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis. Larghero J; Farge D; Braccini A; Lecourt S; Scherberich A; Foïs E; Verrecchia F; Daikeler T; Gluckman E; Tyndall A; Bocelli-Tyndall C Ann Rheum Dis; 2008 Apr; 67(4):443-9. PubMed ID: 17526552 [TBL] [Abstract][Full Text] [Related]
12. Migration of human umbilical cord blood mesenchymal stem cells mediated by stromal cell-derived factor-1/CXCR4 axis via Akt, ERK, and p38 signal transduction pathways. Ryu CH; Park SA; Kim SM; Lim JY; Jeong CH; Jun JA; Oh JH; Park SH; Oh WI; Jeun SS Biochem Biophys Res Commun; 2010 Jul; 398(1):105-10. PubMed ID: 20558135 [TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of ephrins and thrombospondins in the dermis of patients with early diffuse systemic sclerosis: potential contribution to perturbed angiogenesis and fibrosis. Avouac J; Clemessy M; Distler JH; Gasc JM; Ruiz B; Vacher-Lavenu MC; Wipff J; Kahan A; Boileau C; Corvol P; Allanore Y Rheumatology (Oxford); 2011 Aug; 50(8):1494-504. PubMed ID: 21454305 [TBL] [Abstract][Full Text] [Related]
14. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Kitaori T; Ito H; Schwarz EM; Tsutsumi R; Yoshitomi H; Oishi S; Nakano M; Fujii N; Nagasawa T; Nakamura T Arthritis Rheum; 2009 Mar; 60(3):813-23. PubMed ID: 19248097 [TBL] [Abstract][Full Text] [Related]
15. Impaired endothelium-mesenchymal stem cells cross-talk in systemic sclerosis: a link between vascular and fibrotic features. Cipriani P; Di Benedetto P; Ruscitti P; Campese AF; Liakouli V; Carubbi F; Pantano I; Berardicurt O; Screpanti I; Giacomelli R Arthritis Res Ther; 2014 Sep; 16(5):442. PubMed ID: 25248297 [TBL] [Abstract][Full Text] [Related]
16. Systemic sclerosis fibroblasts inhibit in vitro angiogenesis by MMP-12-dependent cleavage of the endothelial cell urokinase receptor. Serratì S; Cinelli M; Margheri F; Guiducci S; Del Rosso A; Pucci M; Fibbi G; Bazzichi L; Bombardieri S; Matucci-Cerinic M; Del Rosso M J Pathol; 2006 Oct; 210(2):240-8. PubMed ID: 16917801 [TBL] [Abstract][Full Text] [Related]
17. VEGF/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart. Tang JM; Wang JN; Zhang L; Zheng F; Yang JY; Kong X; Guo LY; Chen L; Huang YZ; Wan Y; Chen SY Cardiovasc Res; 2011 Aug; 91(3):402-11. PubMed ID: 21345805 [TBL] [Abstract][Full Text] [Related]
18. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection. Herrmann JL; Wang Y; Abarbanell AM; Weil BR; Tan J; Meldrum DR Shock; 2010 Jan; 33(1):24-30. PubMed ID: 19996917 [TBL] [Abstract][Full Text] [Related]
19. MEK mediates the novel cross talk between TNFR2 and TGF-EGFR in enhancing vascular endothelial growth factor (VEGF) secretion from human mesenchymal stem cells. Wang Y; Wang M; Abarbanell AM; Weil BR; Herrmann JL; Tan J; Novotny NM; Coffey AC; Meldrum DR Surgery; 2009 Aug; 146(2):198-205. PubMed ID: 19628074 [TBL] [Abstract][Full Text] [Related]
20. Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells. Menon LG; Picinich S; Koneru R; Gao H; Lin SY; Koneru M; Mayer-Kuckuk P; Glod J; Banerjee D Stem Cells; 2007 Feb; 25(2):520-8. PubMed ID: 17053212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]